<DOC>
	<DOCNO>NCT00480922</DOCNO>
	<brief_summary>There recent increase incidence obesity associate morbidity , include T2 DM , hypertension hepatic steatosis . Hepatic steatosis precursor non-alcoholic steatohepatitis , cirrhosis end-stage liver disease . The 1st report case pediatric hepatic steatosis 1980 affect 30-77 % overweight child . In addition association obesity , hepatic steatosis associate metabolic syndrome , insulin resistance , post-prandial hyperglycemia . Current treatment hepatic steatosis include weight loss hypocaloric low fat diet . Given association insulin resistance post-prandial hyperglycemia , adult patient hepatic steatosis respond weight loss place insulin sensitize drug . We hypothesize weight loss diet design decrease insulin resistance post-prandial hyperglycemia , low glycemic load diet , provide safe effective way decrease hepatic fat content pediatric population . This hypothesis test randomize control trial compare effect low fat diet low glycemic load diet .</brief_summary>
	<brief_title>Effects Low Glycemic Load Diet Fatty Liver Children</brief_title>
	<detailed_description />
	<mesh_term>Fatty Liver</mesh_term>
	<criteria>BMI &gt; 95th percentile age sex Weight &lt; 300 pound Ability lie quietly MRI approximately 45 minute Willing able attend session . Working telephone Greater equal 10 % hepatic steatosis nMR spectroscopy Any medical condition besides obesity may predispose liver disease Medications affect liver metabolism Any cause chronic hepatitis Diabetes Inability adhere prescribe diet Currently highdose vitamin willing discontinue Weight loss/gain past 6 month &gt; 10 % total body weight . Sibling subject already enrol Any alcohol consumption</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>non-alcoholic fatty liver disease</keyword>
	<keyword>steatohepatitis</keyword>
	<keyword>overweight</keyword>
	<keyword>insulin resistance</keyword>
</DOC>